Skip to content
DataLookout
Menu

QUBIPANNCT07868120

Brain Iron in Beta-Propeller Protein Associated Neurodegeneration (BPAN)

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Brain Iron
Timeframe: Baseline (T0), month 18 (T18).

Secondary (1)

Correlation between intracerebral iron levels and clinical symptom severity

Arms and interventions

Patients with genetically confirmed BPANExperimental

Each participant will be followed for 18 months, with two main study visits (baseline and 18 months). Clinical and imaging data will be collected at each visit as part of routine care and study procedures. Additional visits may occur if clinically indicated

Other: Standardized brain MRI including specific sequences usable for Quantitative Susceptibility Mapping (QSM)

Sites

1 site in 1 country

  • CHU de BordeauxBordeaux, France